| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193325 | Annals of Allergy, Asthma & Immunology | 2007 | 7 Pages |
Abstract
Indacaterol had a good overall safety profile and was well tolerated at both doses, with predose FEV1 results on days 14 and 28 indicating 24-hour bronchodilator efficacy.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
William H. MD, Jean Benoit MD, Petr MD, Jutta MD, Daniel MD, Ray BSc (Hons), Roger PhD, Mark MD,